
Reset all filters
01 8Gowling WLG (Canada) LLP
Reset all filters
01 22693901
02 22873979
03 22933623
04 23024208
Reset all filters
01 8ENTRECTINIB
Reset all filters
01 8CAPSULE
Reset all filters
01 22028-07-08
02 22033-05-22
03 22035-02-19
04 22037-05-18
Patent Expiration Date : 2028-07-08
Date Granted : 2015-12-29
Brand Name : ROZLYTREK
Patent Number : 2693901
Filing Date : 2008-07-08
Strength per Unit : 100 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-07-08
Date Granted : 2015-12-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-05-22
Date Granted : 2019-11-12
Brand Name : ROZLYTREK
Patent Number : 2873979
Filing Date : 2013-05-22
Strength per Unit : 100 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-05-22
Date Granted : 2019-11-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-07-08
Date Granted : 2015-12-29
Brand Name : ROZLYTREK
Patent Number : 2693901
Filing Date : 2008-07-08
Strength per Unit : 200 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-07-08
Date Granted : 2015-12-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-05-22
Date Granted : 2019-11-12
Brand Name : ROZLYTREK
Patent Number : 2873979
Filing Date : 2013-05-22
Strength per Unit : 200 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-05-22
Date Granted : 2019-11-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-02-19
Date Granted : 2022-05-17
Brand Name : ROZLYTREK
Patent Number : 2933623
Filing Date : 2015-02-19
Strength per Unit : 100 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-02-19
Date Granted : 2022-05-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2037-05-18
Date Granted : 2022-07-26
Brand Name : ROZLYTREK
Patent Number : 3024208
Filing Date : 2017-05-18
Strength per Unit : 100 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2037-05-18
Date Granted : 2022-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-02-19
Date Granted : 2022-05-17
Brand Name : ROZLYTREK
Patent Number : 2933623
Filing Date : 2015-02-19
Strength per Unit : 200 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2035-02-19
Date Granted : 2022-05-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2037-05-18
Date Granted : 2022-07-26
Brand Name : ROZLYTREK
Patent Number : 3024208
Filing Date : 2017-05-18
Strength per Unit : 200 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2037-05-18
Date Granted : 2022-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF